Cinacalcet is a medicine used to help lower high calcium levels in the blood. It works by telling the kidneys to remove more calcium from the body. This is often used to treat conditions like high calcium levels caused by certain types of cancer or kidney disease.
Every report comes from a Lived member, sent anonymously.
Have you tried Sensipar (Cinacalcet) for Secondary Hyperparathyroidism?
Cinacalcet, sold under the brand name Sensipar and as a generic, is a prescription tablet that lowers parathyroid hormone (PTH) and blood calcium. The parathyroid glands are four small glands in the neck that make PTH, which keeps calcium and phosphorus in balance. When they make too much, the condition is called hyperparathyroidism. Its main use is secondary hyperparathyroidism in adults with chronic kidney disease who are on dialysis. Failing kidneys disturb calcium, phosphorus and vitamin D, and the parathyroid glands respond by overproducing PTH, which over time weakens bones and contributes to mineral deposits in blood vessels. Cinacalcet is not approved for people with kidney disease who are not yet on dialysis, because their calcium tends to drop too low on it. It is also approved to bring down dangerously high calcium in adults with parathyroid cancer, and in adults with primary hyperparathyroidism (an overactive gland, usually from a benign growth) whose calcium is high enough to need surgery but who cannot have the operation. For most people with primary hyperparathyroidism, surgery remains the standard treatment. Cinacalcet is not a general treatment for high calcium from other causes.
Each parathyroid gland has a calcium sensor on its surface. When the sensor detects enough calcium in the blood, the gland makes less PTH. Cinacalcet belongs to a group of drugs called calcimimetics: it makes that sensor more responsive, so the gland behaves as if calcium were higher than it is and cuts back on PTH. Less PTH means less calcium is pulled into the blood, so blood calcium falls along with PTH. That is the intended effect, but it is also why the main risk of cinacalcet is calcium dropping too low.
Cinacalcet is taken by mouth with food or shortly after a meal. Tablets should be swallowed whole, not chewed, crushed or split. Treatment starts at a low dose (once a day for people on dialysis, twice a day for parathyroid cancer or primary hyperparathyroidism) and is increased step by step, no more often than every two to four weeks, based on blood test results. People on dialysis often take it alongside vitamin D medicines and phosphate binders (medicines that reduce phosphorus absorbed from food), and the team adjusts these together. Dose changes should come from the prescriber, guided by the latest calcium and PTH results.
Nausea and vomiting are the most common side effects, affecting roughly a quarter or more of people in studies. Persistent nausea or vomiting is worth reporting, since it can sometimes be managed with a dose change. Diarrhea, muscle aches, dizziness and loss of appetite are also reported. The most important risk is low blood calcium (hypocalcemia). It is often found on routine blood tests before any symptoms, which is one reason regular testing matters. When symptoms occur, they include tingling or numbness around the mouth or in the fingers, muscle aches, and cramps or spasms in the hands, feet or face; contact the care team promptly if these appear. Severe low calcium can trigger seizures and dangerous heart rhythm changes and has been fatal in rare cases. A seizure is an emergency: call 911. Bleeding in the upper digestive tract has occurred, more often in people with ulcers, stomach inflammation or severe vomiting. Vomiting blood or material that looks like coffee grounds, or black, tarry stools, should be reported to a clinician right away.
Cinacalcet is not started when blood calcium is already below the normal range. It should not be combined with other calcium-lowering treatments without close monitoring; in particular, etelcalcetide (Parsabiv), an injected calcimimetic given during dialysis, is stopped at least four weeks before switching to cinacalcet. Cinacalcet slows the liver's breakdown of some other medicines, raising their levels. This matters most for flecainide (a heart rhythm medicine) and most tricyclic antidepressants, an older group of antidepressants, where small changes in level can cause harm; it can also affect beta blockers such as metoprolol and carvedilol. In the other direction, strong antifungals such as ketoconazole and itraconazole can raise cinacalcet levels. Starting or stopping any of these is a reason to check doses and blood tests. People with heart failure or other heart conditions may need extra monitoring, because low blood pressure, worsening heart failure and abnormal heart rhythms have been reported. Those with a personal or family history of long QT syndrome (a heart rhythm disorder), a seizure disorder, or moderate to severe liver disease also need closer calcium checks. Data in pregnancy and breastfeeding are limited, and safety has not been established in children.
PTH and calcium usually start to fall within the first weeks, and the dose is adjusted over several months to reach the target. Calcium is checked within about a week of starting or changing the dose, and PTH within one to four weeks. Once the dose is stable, people on dialysis typically have calcium checked about monthly, and those treated for parathyroid cancer or primary hyperparathyroidism about every two months. On dialysis, cinacalcet lowers PTH and calcium and roughly halves the chance of needing surgery to remove the parathyroid glands. Large studies, however, did not find that it helps people live longer or prevents heart attacks and other heart events, so it is best understood as a way to control hormone and mineral levels and avoid or delay surgery. Pushing PTH too low is also undesirable, because it can lead to adynamic bone disease, in which bone stops renewing itself normally; the target is a range, not as low as possible. For parathyroid cancer or primary hyperparathyroidism, cinacalcet can bring high calcium down but does not remove the overactive or cancerous tissue causing it, so its effect lasts only as long as it is taken.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Sensipar (Cinacalcet), what you've noticed, or ask the community a question.